ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 5176

$1.89M Total Retail Price of All Prescriptions

Rank: 60 out of 5176

522 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 19,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

55% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,623 1,499 10 1 16
AMLODIPINE BESYLATE 1,595 1,504 2 2
ALENDRONATE SODIUM 1,156 1,131 3 18
DIOVAN 1,058 1,006 4 19
LIDODERM 813 779 5 59
EVISTA 794 738 6 65
SIMVASTATIN 702 666 7 1
METFORMIN HCL 621 575 8 7
GLIMEPIRIDE 507 486 9 37
TAMSULOSIN HCL 470 447 10 20
METOPROLOL SUCCINATE 464 464 11 11
ATORVASTATIN CALCIUM 402 352 12 9
OMEPRAZOLE 380 351 13 3
LOSARTAN POTASSIUM 375 338 14 14
JANUVIA 328 319 15 25
DIOVAN HCT 317 312 16 39
CRESTOR 311 304 17 15
FLUTICASONE PROPIONATE 294 252 18 38
ATENOLOL 262 254 19 12
AVODART 218 218 20 107
LOVAZA 214 203 21 43
AMMONIUM LACTATE 201 184 22 91
CLOPIDOGREL 194 193 23 26
SINGULAIR 193 185 24 62
PLAVIX 183 183 25 29
PATANOL 156 130 26 158
AMLODIPINE BESYLATE-BENAZEPRIL 156 156 26 55
FENOFIBRATE 155 148 28 102
TRICOR 153 153 29 148
ACTOS 148 148 30 85
GABAPENTIN 142 136 31 21
LEVOTHYROXINE SODIUM 141 140 32 4
HYDROCHLOROTHIAZIDE 136 136 33 10
PROCTOZONE-HC 136 128 33 171
PRAVASTATIN SODIUM 135 110 35 23
NIFEDIPINE ER 125 117 36 48
CHLORHEXIDINE GLUCONATE 123 114 37 202
ISOSORBIDE MONONITRATE ER 123 123 37 44
VOLTAREN 122 98 39 97
METOPROLOL TARTRATE 112 107 40 6
POLYETHYLENE GLYCOL 3350 110 102 41 74
AZITHROMYCIN 109 100 42 42
GLIPIZIDE XL 107 102 43 83
LIPITOR 105 100 44 51
SYNTHROID 103 91 45 33
CLOBETASOL PROPIONATE 102 95 46 130
LOSARTAN-HYDROCHLOROTHIAZIDE 100 99 47 35
LIDOCAINE 100 77 47 179
MONTELUKAST SODIUM 97 90 49 123
PROAIR HFA 97 96 49 60
DONEPEZIL HCL 96 96 51 28
VIREAD 96 85 51 250
MECLIZINE HCL 86 79 53 81
LANSOPRAZOLE 85 80 54 113
BENICAR 80 80 55 100
CLOTRIMAZOLE-BETAMETHASONE 77 71 56 94
ENALAPRIL MALEATE 75 75 57 22
MICARDIS 70 70 58 154
ONGLYZA 67 67 59 153
AMOXICILLIN 66 54 60 163
DEXILANT 65 58 61 118
PIOGLITAZONE HCL 61 58 R 62 237
BYSTOLIC 61 61 62 96
PROMETHAZINE HCL 61 53 R 62 221
SINGLE USE SWAB 60 56 65 108
AGGRENOX 59 59 66 235
ZETIA 58 58 67 68
DETROL LA 58 58 67 249
CARVEDILOL 56 42 69 24
TRIAMCINOLONE ACETONIDE 56 53 69 125
DOXAZOSIN MESYLATE 54 54 71 103
ALLOPURINOL 53 53 72 41
NAMENDA 51 51 73 47
ATELVIA 51 51 73 146
GLYBURIDE-METFORMIN HCL 50 50 R 75 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.